Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

about

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

Item

http://www.wikidata.org/entity/Q36815913

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

@ast

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

@en

type

Item

label

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

@ast

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

@en

prefLabel

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

@ast

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

@en

P1476

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey

@en

P2093

Adem Deligonul

http://www.w3.org/2001/XMLSchema#string

Ali Topak

http://www.w3.org/2001/XMLSchema#string

Ender Kurt

http://www.w3.org/2001/XMLSchema#string

Mehmet Ture

http://www.w3.org/2001/XMLSchema#string

Orhan Gorukmez

http://www.w3.org/2001/XMLSchema#string

Ozlem Gorukmez

http://www.w3.org/2001/XMLSchema#string

Sebnem Ozemri Sag

http://www.w3.org/2001/XMLSchema#string

Serdar Sahinturk

http://www.w3.org/2001/XMLSchema#string

Tahsin Yakut

http://www.w3.org/2001/XMLSchema#string

Tuna Gulten

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Molecular biology of lung cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Cancer statistics, 2010

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features

P2888

s40064-016-2150-4

P304

482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-016-2150-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1004860159

http://www.w3.org/2001/XMLSchema#string

P698

27217997

http://www.w3.org/2001/XMLSchema#string

P932

4837752

http://www.w3.org/2001/XMLSchema#string